sellWeak
Trisha L Fox sold $20k of OLPX
Chief People Officer at OLAPLEX HOLDINGS, INC.. 16,840 shares at an average of $1.21, traded May 23, 2025, filed May 27, 2025.
Warning score
15Value
$20k
16,840 shares
Holdings after
763,220
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$20k at market
- 0Share of holdings soldSold 2.2% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001868726-25-000063, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 23, 2025 | SOpen-market sale Common Stock | -16,840 | $1.21 | $20k | 763,220 | May 27, 2025 |
Related signals
Other insiders at OLAPLEX HOLDINGS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | OLPXsell OLAPLEX HOLDINGS, INC. | John C Duffy General Counsel | $15k 11,730 shares | -2% | |
| 23Weak | OLPXbuy OLAPLEX HOLDINGS, INC. | Kenneth F Egan See Remarks. | $13k 10,000 shares | - | |
| 30Weak | OLAPLEX HOLDINGS, INC. | John C Duffy General Counsel | $50k 35,013 shares | -9% | |
| 29Weak | OLAPLEX HOLDINGS, INC. | Trisha L Fox Chief People Officer | $38k 26,526 shares | -5% | |
| 52Moderate | OLPXsell OLAPLEX HOLDINGS, INC. | Amanda Baldwin Chief Executive Officer | $803k 382,555 shares | -12% | |
| 40Moderate | OLAPLEX HOLDINGS, INC. | John P Bilbrey director | $135k 76,825 shares | +32% | |
| 41Moderate | OLAPLEX HOLDINGS, INC. | Amanda Baldwin Chief Executive Officer | $74k 43,000 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.